Skip to Main Content

Paper Details

A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation.
Crit Care Med
215
2013
Author NameAffiliation
Jean-Louis VincentErasme Hospital, Universite libre de Bruxelles
  • 1 - 1

Datasets

Release 1.2